Skip to main content

Be confident that your patient care is up to date

Register now and start receiving our tailored medical education content from April. You can also secure your place for the first live webinar.

IN FOCUS | Genitourinary cancers

Patient taking tablets

30-06-2023 | Prostate cancer | News

First-line talazoparib plus enzalutamide supported for mCRPC

Adding talazoparib to enzalutamide significantly improves the outcomes of untreated patients with metastatic castration-resistant prostate cancer, regardless of homologous recombination repair mutation status, shows the TALAPRO-2 trial.

IN FOCUS | Lung & thoracic cancers

Asian woman taking tablet

06-06-2023 | Non-small-cell lung cancer | Conference coverage | News

ADAURA demonstrates OS gain with adjuvant osimertinib in early-stage NSCLC

Adjuvant treatment with osimertinib significantly prolongs overall survival relative to placebo in people with EGFR-mutated, early-stage non-small-cell lung cancer, show trial results.

IN FOCUS | Breast cancer

Mammogram image on a screen with the scanner in the background

16-08-2023 | Breast cancer | News

AI-supported mammography matches standard screen-detected breast cancer rate

Preliminary MASAI trial results indicate that AI-supported mammography has a similar rate of breast cancer detection to standard double reading while reducing the screen-reading workload.

IN FOCUS | COVID-19 & cancer

Woman with drip and mask

30-08-2023 | COVID-19 | News

Cancer treatment linked to increased risk for COVID-19-related VTE

An analysis of the CCC19 registry has demonstrated a significant link between receipt of anticancer therapies within 3 months of a COVID-19 diagnosis and an elevated risk for venous thromboembolism